Summary: New research shows that childhood maltreatment leaves measurable biological “scars” on DNA and is associated with lasting changes in brain structure and function. A genome-wide epigenetic analysis identified four DNA methylation sites—ATE1, SERPINB9P1, CHST11, and FOXP1—that consistently relate to maltreatment exposure.
Alterations in FOXP1 were particularly notable: higher methylation at this site correlated with differences in gray matter in brain areas involved in emotion, memory, and social cognition. These results provide a biological link between early trauma and later behavioral and mental health outcomes, and point toward objective markers that could support early detection and trauma-informed care.
Key Facts:
- Epigenetic markers: Four CpG methylation sites were identified as consistent biomarkers associated with child maltreatment.
- FOXP1 significance: Hypermethylation of FOXP1 was linked to structural brain changes in regions that govern emotional and social processing.
- Predictive tool: A methylation risk score (MRS) derived from these four sites distinguished individuals with a history of maltreatment in independent data.
Source: University of Fukui
Child maltreatment—encompassing abuse and neglect—remains a major public health concern worldwide. Beyond the immediate psychological harm, early adversity can leave durable effects on brain development and biological systems, in part through epigenetic modifications that alter gene regulation.
Until now, the precise molecular signatures that link childhood trauma to lasting brain changes have been incompletely understood. The new study, led by Senior Assistant Professor Shota Nishitani and Professor Akemi Tomoda at the Research Center for Child Mental Development, University of Fukui, with collaboration from Professor Masataka Nagao at Hiroshima University, reports robust epigenetic markers of maltreatment and connects them to neuroanatomical differences.
Published in Molecular Psychiatry on September 16, 2025, the study expanded on earlier work from Prof. Tomoda’s group that suggested maltreatment can modify DNA methylation. Instead of focusing on a few candidate genes, the team performed a genome-wide, multi-cohort analysis to uncover reliable methylation signatures and to evaluate their relationship with brain structure.
The investigators analyzed epigenomic data across three distinct cohorts: judicial autopsy cases, toddlers shortly after protective social interventions, and adolescents who had received protective interventions and brain MRI scans. Each group was examined separately and then combined via meta-analysis to identify common methylation sites associated with childhood maltreatment.
Across these analyses, four CpG sites reached consistent association with maltreatment: ATE1, SERPINB9P1, CHST11, and FOXP1. DNA methylation at these sites alters gene regulation without changing the underlying DNA sequence, and can therefore serve as a molecular record of environmental exposures.
FOXP1 emerged as particularly important. This gene functions as a regulator of developmental programs in the brain. The study found that greater methylation at FOXP1 was associated with measurable gray matter changes: increased gray matter volume in the orbitofrontal cortex and parts of the cingulate gyrus, and decreased gray matter volume in the occipital fusiform gyrus. These regions contribute to emotional regulation, memory retrieval, and social cognition, providing a plausible neurobiological pathway from early trauma to later psychopathology.
“Childhood trauma does not only affect emotional experience; it leaves biological marks at the molecular and brain levels,” says Professor Tomoda. Identifying these epigenetic markers could support earlier and more objective detection of maltreatment exposure and enable interventions that are tailored to the needs of affected children.
To test clinical and forensic utility, the researchers combined the four methylation sites into a methylation risk score (MRS). Applied to an independent validation dataset, the MRS differentiated individuals with and without documented early-life adversity, suggesting the potential for an objective screening measure that complements clinical assessment.
These findings have implications across health care, forensic investigation, and public policy. In clinical settings, validated biomarkers could support earlier diagnosis and personalized, trauma-informed treatment. In forensic contexts, biological evidence might aid investigations into suspected maltreatment. At a population level, screening tools informed by epigenetic markers could help direct preventive resources to at-risk children and reduce the long-term societal burden of maltreatment.
The study aligns with the mission of the Division of Developmental Support Research at the University of Fukui, which integrates neuroscience, clinical practice, and community-based strategies to promote resilience and well-being among children and families. The division prioritizes early detection, intervention, and prevention of developmental and mental health difficulties.
“Childhood should be a time of safety and growth,” emphasizes Professor Tomoda. “A clearer understanding of how early trauma becomes biologically embedded can guide better prevention, treatment, and support to break cycles of maltreatment.”
Key Questions Answered:
A: Childhood maltreatment is associated with changes in DNA methylation—epigenetic marks that modify gene activity. In this study, methylation changes, especially at FOXP1, were linked to structural brain differences in regions involved in emotion and memory.
A: The orbitofrontal cortex, cingulate gyrus, and occipital fusiform gyrus showed measurable gray matter alterations related to FOXP1 methylation. These areas are important for emotional regulation, memory retrieval, and social cognition.
A: By providing objective biological evidence of trauma exposure and its links to brain structure, these epigenetic markers could support earlier identification of at-risk children, inform trauma-focused interventions, and contribute to prevention strategies.
About this genetics, neurodevelopment, and mental health research news
Author: Yuuka Kawamoto
Source: University of Fukui
Contact: Yuuka Kawamoto, University of Fukui
Image: The image is credited to Neuroscience News
Original Research: Open access. “Multi-epigenome-wide analyses and meta-analysis of child maltreatment in judicial autopsies and intervened children and adolescents” by Masataka Nagao et al., Molecular Psychiatry. DOI: 10.1038/s41380-025-03236-1
Abstract
Multi-epigenome-wide analyses and meta-analysis of child maltreatment in judicial autopsies and intervened children and adolescents
Child maltreatment is linked to a wide range of adverse physical, psychological, and neurodevelopmental outcomes. Epigenetic changes, and DNA methylation in particular, are plausible mechanisms that may explain how early adversity produces long-term effects on health and brain function.
To find robust methylation signatures associated with maltreatment, the study conducted epigenome-wide analyses across three independent cohorts: judicial autopsy cases (CM:11, Controls:7), toddlers assessed shortly after social intervention (CM:36, Controls:49), and adolescents who underwent brain MRI (CM:61, Controls:62). Each cohort was examined individually, and results were combined through meta-analysis to identify common CpG sites associated with exposure to maltreatment.
The meta-analysis identified four CpG sites located in ATE1, SERPINB9P1, CHST11, and FOXP1. Methylation at FOXP1 was repeatedly associated with structural brain alterations—greater gray matter volume in the orbitofrontal cortex and middle/posterior cingulate gyrus, and reduced gray matter volume in the occipital fusiform gyrus—regions implicated in emotion, memory, and social cognition.
Methylation risk scores calculated from these four CpGs discriminated individuals exposed to early adversity in an independent validation cohort, achieving an area under the ROC curve (AUC) of 0.672. Gene ontology and pathway analyses highlighted enrichment in cholinergic and glutamatergic synaptic transmission pathways, supporting a role for these systems in traumatic memory formation.
These results contribute new insights into the epigenetic mechanisms through which child maltreatment may influence brain development and mental health, and they identify candidate biomarkers that could support early detection, prevention, and targeted therapeutic strategies to reduce the long-term burden of maltreatment.